Previous studies have shown that the regional patterns of tau-PET signal not only closely mirror the clinical representation of AD-related clinical syndromes [48] but also with future patterns of brain atrophy [23, 24] as well as are correlated with domain-specific cognitive impairments [48–50]. This evidence concerns the gene MAPT and Alzheimer disease.